Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Schwartz said it all.....Or, perhaps didn't say enough
3
Oct 23, 2007 12:47PM
1
Oct 23, 2007 12:50PM

While I wasn't there, I know the answer is yes.  It's called acquisition/merger with a company/companies that can provide a positive and recurring cash flow.

I think the litigation determines mainly the scale of the acquisition/merger.

Agree?

1
Oct 23, 2007 01:07PM
1
Oct 23, 2007 01:51PM
Share
New Message
Please login to post a reply